Skip to main content
FranchiseVerdict

R3vive vs 986 Pharmacy

Franchise Comparison 2026

FDDs: R3vive 2022, 986 Pharmacy 2026SBA 7(a) data through FY2026Updated How we score

Not like-for-like: these figures come from FDDs of different years (2022, 2026). Costs, fees and unit counts change from one filing to the next, so the older column may be out of date.

Both R3vive and 986 Pharmacy are franchises in the healthcare category. R3vive requires an investment of $262K – $669K while 986 Pharmacy requires $295K – $671K. Neither R3vive nor 986 Pharmacy makes a financial performance representation in Item 19 of its FDD — a voluntary item under the FTC Franchise Rule — so the two cannot be compared on disclosed gross sales. FranchiseVerdict rates R3vive B (Second tier) and 986 Pharmacy A (Strongest tier).

Investment Range
$262K – $669K
$295K – $671K
Franchise Fee
$75K
$50K
Royalty Rate
6.0%
Continuing License Fee: $1,650 per month for the first 12 months, then $2,100 per month for the rest of the term; may be increased annually by up to 5% on July 1. No percentage-of-sales royalty.
Average Gross Sales (Item 19)
N/ANot disclosed
N/ANot disclosed
SBA Charge-Off Rate
N/A
Limited data
Total Units
10
46
Unit Growth (YoY)
+2 units
+2 units
Year Began Franchising
2020
N/A
FDD Year
2022
2026

Next step

  • Browse free

    Every brand with an FDD on file, graded, with costs, disclosed sales and SBA records. No sign-in.
  • Pro

    For advisors and lenders working across many brands; inquire by email.